Literature DB >> 15690555

Cervical length as a prognostic factor for preterm delivery in twin-to-twin transfusion syndrome treated by fetoscopic laser coagulation of chorionic plate anastomoses.

R Robyr1, M Boulvain, L Lewi, A Huber, K Hecher, J Deprest, Y Ville.   

Abstract

OBJECTIVE: To evaluate the risk of spontaneous preterm delivery in relation to cervical length in severe cases of twin-to-twin transfusion syndrome (TTTS) diagnosed before 26 weeks of gestation and treated by laser coagulation of the intertwin placental anastomoses.
METHODS: This was an observational study of cases of severe TTTS diagnosed before 26 weeks of gestation and treated by fetoscopic laser coagulation between January 2002 and December 2003 in three centers. Laser was the first-line treatment in all cases. Elective preterm deliveries before 34 weeks' for maternal or fetal indications, including intrauterine death of both fetuses, were excluded. Transvaginal sonographic measurement of cervical length prior to laser treatment and other risk factors of preterm delivery were evaluated by univariate and logistic regression analysis.
RESULTS: Among the 137 women included, the mean cervical length was 32 and 38 mm in women delivering before and at or after 34 weeks, respectively (P < 0.001). For a cervical length of < 30 mm, the risk of delivery before 34 weeks was 74%. Severity of the disease, deepest vertical pool of amniotic fluid and amniotic fluid volume drained after the procedure were not associated with preterm delivery. Logistic regression analysis identified three independent factors to predict preterm delivery: short cervical length (increased risk), parity (increased risk) and intrauterine death of one twin (decreased risk).
CONCLUSION: In TTTS treated by laser, without indications for elective preterm birth, cervical length before treatment is significantly associated with gestational age at delivery, and this is independent of parity, intrauterine death of one fetus and other risk factors. Copyright (c) 2004 ISUOG.

Entities:  

Mesh:

Year:  2005        PMID: 15690555     DOI: 10.1002/uog.1798

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

1.  Histologic changes of the fetal membranes after fetoscopic laser surgery for twin-twin transfusion syndrome.

Authors:  Ramesha Papanna; Lovepreet K Mann; Kenneth J Moise; Themis Kyriakides; Anthony Johnson; Elisa Garcia; Catalin S Buhimschi; Irina A Buhimschi
Journal:  Pediatr Res       Date:  2015-05-28       Impact factor: 3.756

2.  Risk factors associated with preterm delivery after fetoscopic laser ablation for twin-twin transfusion syndrome.

Authors:  R Papanna; D Block-Abraham; L K Mann; I A Buhimschi; M Bebbington; E Garcia; N Kahlek; C Harman; A Johnson; A Baschat; K J Moise
Journal:  Ultrasound Obstet Gynecol       Date:  2014-01       Impact factor: 7.299

3.  Effect of Cervical Length Recovery after Laser Surgery for Twin-Twin Transfusion Syndrome.

Authors:  Matthew Finneran; Lorene Temming; Megan Templin; Courtney Stephenson
Journal:  AJP Rep       Date:  2016-03

4.  Internal driving factors leading to extrahepatic manifestation of the hepatitis C virus infection.

Authors:  Zhou-Yi Wu; Jian-Rui Li; Meng-Hao Huang; Jun-Jun Cheng; Hu Li; Jin-Hua Chen; Xiao-Qin Lv; Zong-Gen Peng; Jian-Dong Jiang
Journal:  Int J Mol Med       Date:  2017-10-05       Impact factor: 4.101

5.  The effect of polyhydramnios on cervical length in twins: a controlled intervention study in complicated monochorionic pregnancies.

Authors:  Neelam Engineer; Keelin O'Donoghue; Ruwan C Wimalasundera; Nicholas M Fisk
Journal:  PLoS One       Date:  2008-12-02       Impact factor: 3.240

6.  Arabin cervical pessary for prevention of preterm birth in cases of twin-to-twin transfusion syndrome treated by fetoscopic LASER coagulation: the PECEP LASER randomised controlled trial.

Authors:  Carlota Rodó; Sílvia Arévalo; Liesbeth Lewi; Isabel Couck; Bettina Hollwitz; Kurt Hecher; Elena Carreras
Journal:  BMC Pregnancy Childbirth       Date:  2017-08-01       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.